V. Jooste

发表

Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales

M. Coleman, B. Rachet, C. Lepage, 2008, The American Journal of Gastroenterology.

Pancreatic cancer: Wait times from presentation to treatment and survival in a population‐based study

V. Bouvier, G. Launoy, V. Jooste, 2016, International journal of cancer.

Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome

M. van Engeland, V. Jooste, M. Weijenberg, 2016, Clinical Epigenetics.

Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer

V. Jooste, A. Bouvier, L. Remontet, 2019, European journal of gastroenterology & hepatology.

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

P. Laurent-Puig, C. Lepage, V. Jooste, 2015, Cancer medicine.

Management of rectal cancer in France in a well-defined population

V. Bouvier, C. Lepage, V. Jooste, 2014, European journal of gastroenterology & hepatology.

Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France

V. Jooste, J. Faivre, C. Lejeune, 2008, The European Journal of Health Economics.

Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997–2004

D. Forman, B. Rachet, V. Bouvier, 2013, British Journal of Cancer.

Unbiased estimates of long‐term net survival of solid cancers in France

G. Launoy, V. Jooste, P. Arveux, 2013, International journal of cancer.

A new approach to estimate time-to-cure from cancer registries data.

V. Jooste, A. Bouvier, C. Binquet, 2018, Cancer epidemiology.

Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes.

J. Cercueil, R. Loffroy, V. Jooste, 2010, The Journal of clinical endocrinology and metabolism.

Are changes in the stomatognatic system able to modify the eye balance in dyslexia

V. Jooste, Y. Boucher, A. Bouvier, 2019 .

Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010

G. Launoy, V. Jooste, J. Faivre, 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Conditional relative survival of cancer patients and conditional probability of death

G. Hédelin, G. Launoy, V. Jooste, 2009, Cancer.

PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes

J. Cercueil, V. Jooste, P. Gambert, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study

V. Jooste, J. Faivre, A. Bouvier, 2010, Gut.

Comorbidities Alone Do Not Explain the Undertreatment of Colorectal Cancer in Older Adults: A French Population‐Based Study

V. Jooste, J. Faivre, V. Quipourt, 2011, Journal of the American Geriatrics Society.

Cancer cure for 32 cancer types: results from the EUROCARE-5 study.

S. Franceschi, G. Gatta, M. Zorzi, 2020, International journal of epidemiology.

Volume of surgical activity and lymph node evaluation for patients with colorectal cancer in France.

V. Bouvier, G. Launoy, V. Jooste, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prevalence of patients with colorectal cancer requiring follow-up or active treatment.

C. Lepage, V. Jooste, J. Faivre, 2009, European journal of cancer.

Current use of MRI in patients with liver metastatic colorectal cancer: a population-based study

J. Cercueil, V. Jooste, A. Bouvier, 2017, European journal of gastroenterology & hepatology.

Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study

C. Lepage, V. Jooste, J. Faivre, 2015, Diseases of the colon and rectum.

Incidence and survival in late liver metastases of colorectal cancer

G. Launoy, C. Lepage, V. Jooste, 2015, Journal of gastroenterology and hepatology.

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.

C. Lepage, V. Jooste, O. Bouché, 2022, European journal of cancer.

Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients.

V. Jooste, P. Gambert, L. Duvillard, 2005, The Journal of clinical endocrinology and metabolism.

Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.

J. Cercueil, V. Jooste, P. Gambert, 2012, Clinical nutrition.

Chronic viral hepatitis and risk of lymphoid malignancies: a retrospective twelve-year population-based cohort study in Côte d'Or, France.

V. Jooste, E. Benzenine, C. Quantin, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load.

V. Jooste, S. Monier, P. Gambert, 2007, American journal of physiology. Endocrinology and metabolism.

Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites

V. Jooste, P. Grosclaude, A. Bouvier, 2022, Cancer.

Socioeconomic Environment and Survival in Patients with Digestive Cancers: A French Population-Based Study

V. Bouvier, G. Launoy, V. Jooste, 2021, Cancers.

Incidence of chronic Philadelphia chromosome negative (Ph−) myeloproliferative disorders in the Côte d'Or area, France, during 1980–99

V. Jooste, F. Girodon, M. Maynadié, 2005, Journal of internal medicine.

Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia.

E. Solary, B. Quesnel, V. Jooste, 2010, Blood.

Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population‐based study of 327 patients

V. Jooste, F. Girodon, P. Johansson, 2013, British journal of haematology.

Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice

C. Lepage, V. Jooste, V. Quipourt, 2022, Cancers.

Early Gastric Cancer: Trends in Incidence, Management, and Survival in a Well-Defined French Population

C. Lepage, V. Jooste, J. Faivre, 2016, Annals of Surgical Oncology.

Erratum to: Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population

C. Lepage, V. Jooste, J. Faivre, 2016, Gastric Cancer.

Colorectal cancer in inflammatory bowel diseases: A population‐based study (1976–2008)

C. Lepage, V. Jooste, J. Faivre, 2012, Inflammatory bowel diseases.

712 PNPLA 3 RS738409 GG HOMOZYGOTE STATUS IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS

V. Jooste, B. Vergès, A. Bouvier, 2012 .

Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma

A. Amiot, I. Sobhani, C. Copie-Bergman, 2017, Leukemia & lymphoma.

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer

V. Jooste, J. Nousbaum, A. Bouvier, 2022, JAMA network open.

Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study

V. Bouvier, V. Jooste, B. Badic, 2022, Cancers.

Apolipoprotein-AII Concentrations are Associated With Liver Steatosis in Patients With Chronic Hepatitis C

V. Jooste, P. Gambert, L. Duvillard, 2007, Digestive Diseases and Sciences.

A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera

V. Jooste, F. Girodon, P. Johansson, 2017, British journal of haematology.

Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis

J. Cercueil, V. Jooste, L. Duvillard, 2015, Diabetic medicine : a journal of the British Diabetic Association.

Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer

C. Lepage, V. Jooste, M. Callanan, 2022, Cancers.

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

V. Jooste, P. Laforêt, B. Eymard, 2016, Brain : a journal of neurology.

Mutations in the RAS‐MAPK, PI(3)K (phosphatidylinositol‐3‐OH kinase) signaling network correlate with poor survival in a population‐based series of colon cancers

Pierre Laurent-Puig, Astrid Lièvre, Nicolas Veyrie, 2008, International journal of cancer.

Focus on an unusual rise in pancreatic cancer incidence in France.

G. Launoy, V. Jooste, A. Bouvier, 2017, International journal of epidemiology.

The HU Regulon Is Composed of Genes Responding to Anaerobiosis, Acid Stress, High Osmolarity and SOS Induction

V. Jooste, J. Oberto, Sabrina Nabti, 2009, PloS one.

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

D. Birnbaum, E. Solary, W. Vainchenker, 2009, Haematologica.

M. van Engeland, V. Jooste, M. Weijenberg, 2016, Clinical Epigenetics.

Immunogenic death of colon cancer cells treated with oxaliplatin

J. Pignon, L. Zitvogel, O. Kepp, 2010, Oncogene.

Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients

P. A. van den Brandt, J. Herman, G. Meijer, 2014, Molecular oncology.

CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer

Matty P Weijenberg, J. Herman, L. van Neste, 2013, Clinical Cancer Research.

Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.

P. Laurent-Puig, V. Jooste, J. Faivre, 2008, Cancer research.

Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.

V. Jooste, A. Bouvier, D. Riethmuller, 2018, Journal of gynecology obstetrics and human reproduction.

Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

M. Abrahamowicz, V. Jooste, C. Quantin, 2021, BMC Medical Research Methodology.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

V. Jooste, P. Gambert, L. Duvillard, 2003 .

Hepatitis C virus–associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis

V. Jooste, P. Gambert, L. Duvillard, 2003, American Journal of Gastroenterology.

Epidemiology and prognosis of synchronous colorectal cancers

C. Lepage, V. Jooste, J. Faivre, 2008, The British journal of surgery.

The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up.

C. Lepage, V. Jooste, J. Faivre, 2008, European journal of cancer.

Incidence and patterns of late recurrences in colon cancer patients

V. Bouvier, G. Launoy, V. Jooste, 2015, International journal of cancer.

Management and prognosis of pancreatic cancer over a 30-year period

C. Lepage, V. Jooste, J. Faivre, 2009, British Journal of Cancer.

Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study

Isabelle Fournel, V. Jooste, J. Faivre, 2011, Gut.

[Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].

G. Defossez, V. Jooste, M. Colonna, 2019, Bulletin du cancer.

The influence of geographical access to health care and material deprivation on colorectal cancer survival: evidence from France and England.

D. Forman, B. Rachet, V. Bouvier, 2014, Health & place.

Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy

M. Abrahamowicz, V. Jooste, J. Faivre, 2008, Statistics in medicine.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S. Sleijfer, F. Collin, M. van Glabbeke, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A Population-based Assessment of the Prognostic Value of the CD19 Positive Lymphocyte Count in B-cell Chronic Lymphocytic Leukemia using Cox and Markov Models

V. Jooste, R. Cailliod, C. Quantin, 2005, European Journal of Epidemiology.

Surgical treatment of digestive cancer in a well-defined elderly population.

V. Jooste, V. Quipourt, A. Bouvier, 2021, Clinics and research in hepatology and gastroenterology.

Trends in incidence of small bowel cancer according to histology: a population-based study

G. Defossez, V. Bouvier, G. Launoy, 2020, Journal of Gastroenterology.

Flexible Modeling of Net Survival and Cure by AML Subtype and Age: A French Population-Based Study from FRANCIM

V. Jooste, M. Callanan, M. Colonna, 2021, Journal of clinical medicine.

Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer

V. Jooste, J. Faivre, F. Bonnetain, 2008, Cancer.

Outcomes of anus squamous cell carcinoma. Management of anus squamous cell carcinoma and recurrences.

Anthony J. Lopez, C. Lepage, V. Jooste, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

AGING AND THERAPEUTIC DELAY IN COLORECTAL CANCER: A FRENCH POPULATION-BASED STUDY

C. Lepage, V. Jooste, J. Faivre, 2016, Journal of Aging Research and Lifestyle.

Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study.

C. Lepage, V. Jooste, J. Faivre, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Incidence and Patterns of Late Recurrences in Rectal Cancer Patients

V. Bouvier, G. Launoy, V. Jooste, 2015, Annals of Surgical Oncology.

The impact of additional life‐table variables on excess mortality estimates

V. Jooste, R. Giorgi, N. Grafféo, 2012, Statistics in medicine.

Competing risk models to estimate the excess mortality and the first recurrent-event hazards

G. Launoy, V. Jooste, R. Giorgi, 2011, BMC medical research methodology.

Influence of non-clinical factors on restorative rectal cancer surgery: An analysis of four specialized population-based digestive cancer registries in France.

V. Bouvier, G. Launoy, V. Jooste, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data

G. Gatta, V. Jooste, R. Capocaccia, 2023, BMC Medical Research Methodology.

Time-to-cure and cure proportion in solid cancers in France. A population based study.

V. Jooste, A. Bouvier, L. Remontet, 2019, Cancer epidemiology.

Reply to “Survivorship experience: More than premature mortality from cancer”

V. Jooste, P. Grosclaude, A. Bouvier, 2022, Cancer.

Time trends in colorectal cancer early postoperative mortality. A French 25-year population-based study

V. Jooste, J. Faivre, A. Bouvier, 2017, International Journal of Colorectal Disease.

Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study

V. Jooste, J. Faivre, S. Grabar, 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study

V. Jooste, J. Faivre, N. Bossard, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Rising Incidence of Pancreatic Cancer in France

C. Lepage, V. Jooste, J. Faivre, 2010, Pancreas.

Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer

V. Jooste, A. Bouvier, O. Boussari, 2019, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Chemotherapy of metastatic colon cancer in France: A population-based study.

C. Lepage, V. Jooste, A. Bouvier, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population

C. Lepage, V. Jooste, J. Faivre, 2017, Gut.

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).

Karin Haustermans, Simone Mathoulin-Pélissier, Julien Taieb, 2014, European journal of cancer.

Mortality Rate and Risk Factors in Patients With Hereditary Pancreatitis: Uni- and Multidimensional Analyses

V. Jooste, P. Ruszniewski, M. Boutron‐Ruault, 2009, The American Journal of Gastroenterology.

Long-Term Relative Survival after Stroke: The Dijon Stroke Registry

Y. Béjot, M. Giroud, V. Jooste, 2019, Neuroepidemiology.

Trends in the management of gastric cancer over a 32-year period: a French population-based study

C. Lepage, V. Jooste, J. Faivre, 2014, Gastric Cancer.

Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population

C. Lepage, V. Jooste, J. Faivre, 2011, BMC Cancer.

Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes

S. Guzzinati, V. Jooste, R. De Angelis, 2023, Frontiers in Oncology.

Biliary tract cancers have distinct epidemiological patterns and clinical characteristics according to tumour site

C. Lepage, V. Jooste, F. Ghiringhelli, 2023, HPB.

Rural-urban differences in the long-term risk of colorectal cancer after adenoma removal: a population-based study.

V. Jooste, J. Faivre, I. Fournel, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Rural-urban inequalities in detection rates of colorectal tumours in the population.

V. Jooste, J. Faivre, I. Fournel, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Time trends in first‐diagnosis rates of colorectal adenomas: a 24‐year population‐based study

V. Jooste, J. Faivre, A. Bouvier, 2008, Alimentary pharmacology & therapeutics.

Factors influencing inclusion in digestive cancer clinical trials: A population-based study.

V. Jooste, I. Fournel, A. Bouvier, 2015, Digestive and Liver Disease.

Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?

G. Launoy, V. Jooste, A. Bouvier, 2008, European Journal of Epidemiology.

V. Jooste, V. Quipourt, A. Bouvier, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Management of hepatitis C patients: a French population-based study.

V. Jooste, J. Miguet, P. Hillon, 2004, Gastroenterologie clinique et biologique.

Net survival in recurrence-free colon cancer patients.

C. Lepage, V. Jooste, J. Faivre, 2019, Cancer epidemiology.

Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: a classic skin rash with a necrotizing myositis and high risk of malignancy.

V. Jooste, W. Stenzel, M. Richard, 2020, Journal of the American Academy of Dermatology.

Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study.

V. Jooste, P. Evrard, E. Monnet, 2006, Journal of hepatology.

Time trends and short term projections of cancer prevalence in France.

V. Jooste, P. Grosclaude, M. Colonna, 2018, Cancer epidemiology.

Is hepatitis C treatment as efficient in the general population as in randomized trials

V. Jooste, J. Faivre, P. Evrard, 2008 .

Age–Period–Cohort Analysis of Stroke Incidence in Dijon From 1985 to 2005

Y. Béjot, M. Giroud, V. Jooste, 2010, Stroke.

Socioeconomic context, distance to primary care and detection of hepatitis C: a French population-based study.

V. Jooste, E. Monnet, A. Minello, 2008, Social science & medicine.

Patterns of care and outcomes in oesophageal cancer.

V. Jooste, J. Faivre, A. Bouvier, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Is the management of hepatitis C patients appropriate? A population‐based study

C. Lepage, V. Jooste, E. Monnet, 2005, Alimentary pharmacology & therapeutics.

Survival variability across hospitals after resection for pancreatic adenocarcinoma: A multilevel survival analysis on a high-resolution population-based study.

V. Bouvier, V. Jooste, O. Dejardin, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Improvement in survival of metastatic colorectal cancer: are the benefits of clinical trials reproduced in population-based studies?

C. Lepage, V. Jooste, J. Faivre, 2013, European journal of cancer.

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

V. Jooste, P. Laforêt, B. Eymard, 2016, Brain : a journal of neurology.

Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study

V. Jooste, J. Faivre, I. Fournel, 2011, Gut.

[Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].

G. Defossez, V. Jooste, I. Baldi, 2019, Bulletin du cancer.